A carregar...
Antioxidative Potentials of Incretin-Based Medications: A Review of Molecular Mechanisms
Glucagon-like peptide 1 receptor agonists and dipeptidyl-peptidase 4 inhibitors are medications used for managing diabetes, mimicking the metabolic effects of incretin hormones. Recent evidence suggests that these medications have antioxidative potentials in the diabetic milieu. The pathophysiology...
Na minha lista:
| Publicado no: | Oxid Med Cell Longev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8099522/ https://ncbi.nlm.nih.gov/pubmed/34007411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/9959320 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|